New Treatment for Glaucoma Developed

Glaucoma is the second leading cause of blindness in the developed world.

Reviewed By:

Querube Quirós, M.D.​

Staff Physician

Dr. Quirós earned her medical degree from Universidad Latina de Panamá and has experience in antiretroviral therapy, hair implants, and cardiothoracic surgery. She presented on awake craniotomy at the 30th International Neurosurgery Congress and is passionate about regenerative medicine.

Take the first step towards the healthier life you deserve.

The Stem Cell Institute has integrated Intranasal MTF Therapy into its autism protocol:

  • MTF therapy features exosomes and over 300 beneficial molecules
  • Works in synergy with our stem cells
  • Offers anti-inflammatory and regenerative effects
  • Delivered in an easy-to-administer aerosol format via the nose
  • To discover more about MTF and its benefits, click here